Scilex Holding Co. (SCLX)
4.89
-0.05
(-1.01%)
USD |
NASDAQ |
Sep 25, 16:00
4.89
0.00 (0.00%)
After-Hours: 16:21
Scilex Cash from Operations (TTM) : -17.27M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -17.27M |
| March 31, 2026 | -3.267M |
| December 31, 2025 | 3.847M |
| September 30, 2025 | 24.09M |
| June 30, 2025 | 21.05M |
| March 31, 2025 | 16.03M |
| December 31, 2024 | 19.41M |
| September 30, 2024 | 11.67M |
| June 30, 2024 | 12.22M |
| March 31, 2024 | -3.459M |
| Date | Value |
|---|---|
| December 31, 2023 | -20.59M |
| September 30, 2023 | -34.43M |
| June 30, 2023 | -37.73M |
| March 31, 2023 | -36.44M |
| December 31, 2022 | -39.43M |
| September 30, 2022 | -47.92M |
| June 30, 2022 | -50.70M |
| March 31, 2022 | -38.62M |
| December 31, 2021 | -28.38M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Oramed Pharmaceuticals, Inc. | -5.811M |
| Semnur Pharmaceuticals, Inc. | -10.49M |
| ANI Pharmaceuticals, Inc. | 189.47M |
| Corcept Therapeutics, Inc. | 109.70M |
| Veru, Inc. | -26.04M |